Commited to Biologic Innovation

Source URL: www.abbvie.ca

Special Authorization Criteria for Biologic Drugs For each disease category specified below, the biologic drugs listed will only be considered for reimbursement if the patient has failed an adequate trial or experienced

Source URL: www.writerscoalition.ca

ASX ANNOUNCEMENT 10 February 2014 Cynata Partners With Leading Biologic Product Manufacturer Cynata Therapeutics Ltd (ASX:CYP), announced today that it has signed a manufacturing agreement

Source URL: cynata.com

Stakeholder Meeting on PDUFA VI Reauthorization September 28, 2015, 1:30 PM – 3.05 PM FDA White Oak Campus, Silver Spring, MD Purpose To discuss the current status of the human drug and biologic review programs, review

Source URL: www.fda.gov

Council Report AVMA Council on Biologic and Therapeutic Agents’ report on cat and dog vaccines Donald J. Klingborg, DVM; David R. Hustead, DVM; Elizabeth A. Curry-Galvin, DVM; Nigel R. Gumley, DVM, DABVP; Steven C. Hen

Source URL: www.avma.org

Site-specific Chemoenzymatic Glycosylation of Peptides For many eukaryotic proteins, processing by post-translational modifications such as glycosylation is a critical step for correct folding and achievement of biologic

Source URL: techtransfer.univie.ac.at

• Chemistry
• Peptides
• Biochemistry
• Molecular biology
• Glycosylation
• Peptidomimetic

IMPORTANT DRUG WARNING Dear Healthcare Provider, The purpose of this letter is to inform you of updated important safety information about XIAFLEX® (collagenase clostridium histolyticum), a biologic medication indicate

Source URL: www.xiaflexrems.com

• Medicine
• Health
• Clinical medicine
• Collagenase clostridium histolyticum
• RTT
• Collagenase
• Adverse effect
• MedWatch
• Allergy
• Tendinosis

≤ Benefits Bulletin≥ April 2013 In This Issue Changes to the Biologic Landscape: The Entry of

Source URL: www.bayneswhite.com

• Economy
• Money
• Finance
• Employment compensation
• Pensions in Canada
• Financial services
• Personal finance
• Pension funds
• Pension

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of patients with mild asthma

Source URL: web.emmes.com

• Medicine
• Immunology
• Clinical medicine
• Food allergies
• Immune system
• Allergology
• RTT
• Allergy
• Milk allergy
• Immunoglobulin E
• Phadia
• Allergen

Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc

Source URL: www.mvpharm.com

• Biotechnology
• Pharmacology
• Biology
• Pharmaceutical sciences
• Savient pharmaceuticals
• Pegloticase
• Food and Drug Administration
• PEGylation
• Forward-looking statement
• Biopharmaceutical
• Biologic license application